These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2720681

  • 1. Optimization of radioimmunotherapy using human malignant melanoma multicell spheroids as a model.
    Kwok CS, Crivici A, MacGregor WD, Unger MW.
    Cancer Res; 1989 Jun 15; 49(12):3276-81. PubMed ID: 2720681
    [Abstract] [Full Text] [Related]

  • 2. 131I-anticarcinoembryonic antigen therapy of LS174T human colon adenocarcinoma spheroids.
    Langmuir VK, McGann JK, Buchegger F, Sutherland RM.
    Cancer Res; 1989 Jun 15; 49(12):3401-6. PubMed ID: 2720694
    [Abstract] [Full Text] [Related]

  • 3. Uptake kinetics of monoclonal antibodies by human malignant melanoma multicell spheroids.
    Kwok CS, Cole SE, Liao SK.
    Cancer Res; 1988 Apr 01; 48(7):1856-63. PubMed ID: 3349464
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ, Khazaeli MB, Mayo MS, Roberson PL.
    Clin Cancer Res; 1999 Oct 01; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [Abstract] [Full Text] [Related]

  • 6. Specific killing of human melanoma cells by 125I-labeled 9.2.27 monoclonal antibody.
    Lindmo T, Boven E, Mitchell JB, Morstyn G, Bunn PA.
    Cancer Res; 1985 Oct 01; 45(10):5080-7. PubMed ID: 4027987
    [Abstract] [Full Text] [Related]

  • 7. Comparisons between two monoclonal antibodies that bind to the same antigen but have differing affinities: uptake kinetics and 125I-antibody therapy efficacy in multicell spheroids.
    Langmuir VK, Mendonca HL, Woo DV.
    Cancer Res; 1992 Sep 01; 52(17):4728-34. PubMed ID: 1511438
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.
    Clarke K, Lee FT, Brechbiel MW, Smyth FE, Old LJ, Scott AM.
    Clin Cancer Res; 2000 Sep 01; 6(9):3621-8. PubMed ID: 10999754
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids, and xenografts in immune-deprived mice.
    Erlichman C, Vidgen D.
    Cancer Res; 1984 Nov 01; 44(11):5369-75. PubMed ID: 6488191
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
    DeNardo GL, DeNardo SJ, Shen S, DeNardo DA, Mirick GR, Macey DJ, Lamborn KR.
    J Nucl Med; 1999 Aug 01; 40(8):1317-26. PubMed ID: 10450684
    [Abstract] [Full Text] [Related]

  • 14. Effects of 131I-labeled TNT-1 radioimmunotherapy on HT-29 human colon adenocarcinoma spheroids.
    Chen FM, Liu CZ, Epstein AL.
    Cancer Immunol Immunother; 1991 Aug 01; 33(3):158-64. PubMed ID: 2044081
    [Abstract] [Full Text] [Related]

  • 15. Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.
    Sutherland R, Buchegger F, Schreyer M, Vacca A, Mach JP.
    Cancer Res; 1987 Mar 15; 47(6):1627-33. PubMed ID: 3545451
    [Abstract] [Full Text] [Related]

  • 16. Recovery from potentially lethal damage and recruitment time of noncycling clonogenic cells in 9L confluent monolayers and spheroids.
    Rodriguez A, Alpen EL, Mendonca M, DeGuzman RJ.
    Radiat Res; 1988 Jun 15; 114(3):515-27. PubMed ID: 3375440
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mathematical model of simultaneous diffusion and binding of antitumor antibodies in multicellular human tumor spheroids.
    McFadden R, Kwok CS.
    Cancer Res; 1988 Jul 15; 48(14):4032-7. PubMed ID: 3383196
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of radiation dose to the nucleus by vesicular internalization of iodine-125-labeled A33 monoclonal antibody.
    Daghighian F, Barendswaard E, Welt S, Humm J, Scott A, Willingham MC, McGuffie E, Old LJ, Larson SM.
    J Nucl Med; 1996 Jun 15; 37(6):1052-7. PubMed ID: 8683300
    [Abstract] [Full Text] [Related]

  • 20. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon.
    Greiner JW, Ullmann CD, Nieroda C, Qi CF, Eggensperger D, Shimada S, Steinberg SM, Schlom J.
    Cancer Res; 1993 Feb 01; 53(3):600-8. PubMed ID: 8425194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.